: Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

: Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

13 Oct    Finance News

A woman receives an injection during phase 3 testing for the Johnson & Johnson vaccine candidate.

Johnson & Johnson via AP

Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing  “an unexplained illness in a study participant.”

See also  Cloudflare fixes fault that caused hundreds of websites like Shopify and Peloton to stop working

Leave a Reply

Your email address will not be published. Required fields are marked *